KEGG   DRUG: Ebribafusp alfa
Entry
D13074                      Drug                                   
Name
Ebribafusp alfa (USAN/INN)
Sequence
(Heavy chain)
QVQLVQSGAE VKKPGASVKV SCKASGYTFT NYYINWVRQA PGQGLEWMGV INPYSGGTSY
NQKFKGRVTM TVDTSTSTAY MELSSLRSED TAVYFCSSPY WGQGTLVTVS SASTKGPSVF
PLAPCSRSTS ESTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS SGLYSLSSVV
TVPSSSLGTK TYTCNVDHKP SNTKVDKRVE SKYGPPCPPC PAPEFEGGPS VFLFPPKPKD
TLMISRTPEV TCVVVDVSQE DPEVQFNWYV DGVEVHNAKT KPREEQFNST YRVVSVLTVL
HQDWLNGKEY KCKVSNKGLP SSIEKTISKA KGQPREPQVY TLPPSQEEMT KNQVSLTCLV
KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSR LTVDKSRWQE GNVFSCSVLH
EALHSHYTQK SLSLSLGGGG GSGGGGSEDC NELPPRRNTE ILTGSWSDQT YPEGTQAIYK
CRPGYRSLGN VIMVCRKGEW VALNPLRKCQ KRPCGHPGDT PFGTGTLTGG NVFEYGVKAV
YTCNEGYQLL GEINYRECDT DGWTNDIPIC EVVKCLPVTA PENGKIVSSA MEPDREYHFG
QAVRFVCNSG YKEIGDEEMH CSDDGFWSKE KPKCVEISCK SPDVINGSPI SQKIIYKENE
RFQYKCNMGY EYSERGDAVC TESGWRPLPS CEEKSCDNPY IPNGDYSPLR IKHRTGDEIT
YQCRNGFYPA TRGNTAKCTS TGWIPAPRCT LK
(Light chain)
DVVMTQSPLS LPVTLGQPAS ISCKSSQSLL DSDGKTYLNW FQQRPGQSPR RLIYLVSKLD
SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCWQGTHFP RTFGGGTKVE IKRTVAAPSV
FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
(Disulfide bridge: H22-H96, H125-L219, H138-H194, H217-H'217, H220-H'220, H252-H312, H358-H416, H450-H495, H481-H509, H514-H558, H543-H570, H575-H621, H607-H634, H639-H680, H666-H691, H696-H738, H723-H749, H'22-H'96, H'138-H'194, H'215-L'219, H'252-H'312, H'358-H'416, H'450-H'495, H'481-H'509, H'514-H'558, H'543-H'570, H'575-H'621, H'607-H'634, H'639-H'680, H'666-H'691, H'696-H'738, H'723-H'749, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  Type
Peptide
Efficacy
Antineoplastic, Complement cascade inhibitor
Comment
Fusion protein
Target
C3d [CPD:C22538]
  Network
nt06513  Complement cascade
Other DBs
CAS: 2839652-75-2
PubChem: 507530389
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system